INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 48 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,000 | -94.1% | 2,800 | -81.2% | 0.00% | – |
| Q2 2019 | $17,000 | +183.3% | 14,876 | +328.7% | 0.00% | – |
| Q1 2019 | $6,000 | -76.0% | 3,470 | -68.8% | 0.00% | – |
| Q4 2018 | $25,000 | -7.4% | 11,131 | +186.1% | 0.00% | – |
| Q3 2018 | $27,000 | -98.2% | 3,890 | -93.8% | 0.00% | – |
| Q2 2018 | $1,474,000 | +671.7% | 62,567 | +795.7% | 0.00% | – |
| Q1 2018 | $191,000 | – | 6,985 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |